A phase II study of weekly docetaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer

被引：0
|
作者：
Son, C. [1 ]
Kim, K. [1 ]
Lee, K. [1 ]
Yang, D. [1 ]
Lee, S. [1 ]
Choi, P. [1 ]
Cho, S. [1 ]
机构：
[1] Dong A Univ, Busan, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18174
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Azuma, Koichi
    Zaizen, Yoshiaki
    Yamashita, Fumie
    Yoshida, Tsukasa
    Naito, Yoshiko
    Okayama, Yusuke
    Miyamoto, Maki
    Hoshino, Tomoaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 472 - 478
  • [42] Phase II study of Docetaxel (D) and Carboplatin (C) combination in advanced Non-Small Cell Lung Cancer (NSCLC)
    Chowdhury, Qamruzzaman
    Begum, Ferdous A.
    Nahar, Ferdous
    Fairuz, Saima
    Faruqui, Mesba
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S673 - S673
  • [43] Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer
    Sakakibara, T.
    Inoue, A.
    Sugawara, S.
    Maemondo, M.
    Ishida, T.
    Usui, K.
    Abe, T.
    Kanbe, M.
    Watanabe, H.
    Saijo, Y.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 795 - 799
  • [44] Phase II study of taxol and carboplatin in advanced non-small cell lung cancer
    Ginopoulos, P
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 503 - 507
  • [45] Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer
    Takeda, K
    Takifuji, N
    Uejima, H
    Yoshimura, N
    Terakawa, K
    Negoro, S
    LUNG CANCER, 2002, 38 (03) : 303 - 308
  • [46] Randomized phase II trial of carboplatin combined with weekly paclitaxel (CP) and docetaxel alone (D) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): NJLCG 0801.
    Sugawara, Shunichi
    Maemondo, Makoto
    Harada, Toshiyuki
    Inoue, Akira
    Matsubara, Nobumichi
    Watanabe, Kana
    Ishimoto, Osamu
    Sakakibara, Tomohiro
    Minegishi, Yuji
    Usui, Kazuhiro
    Ando, Masahiro
    Morikawa, Naoto
    Mori, Yoshiaki
    Gemma, Akihiko
    Nukiwa, Toshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] A phase II study of docetaxel and carboplatin in patients with advanced non-small cell lung cancer after treatment with non-platinum regimens
    Ikeda, T.
    Fukuda, M.
    Fukuda, M.
    Soejima, Y.
    Doi, S.
    Nagashima, S.
    Nakamura, Y.
    Soda, H.
    Oka, M.
    Kohno, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Phase II study of weekly gemcitabine in advanced non-small cell lung cancer
    Halme, M
    Jekunen, A
    Tamminen, K
    Mattson, K
    RESPIRATORY MEDICINE, 1997, 91 (07) : 423 - 426
  • [49] A PHASE II STUDY OF WEEKLY PACLITAXEL COMBINED WITH CARBOPLATIN VERSUS THE STANDARD EVERY 3-WEEKS PACLITAXEL AND CARBOPLATIN FOR ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SMALL CELL LUNG CANCER
    El Shenshawy, H. M.
    Taema, S.
    ElZahaaf, E.
    Eldeen, D. Sharaf
    Elbeshbeshi, W.
    Fathy, A.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S71 - S72
  • [50] Phase II study of weekly carboplatin and irinotecan as first-line chemotherapy for patients with advanced non-small cell lung cancer
    Kim, Hyeong Su
    Kim, Jung Han
    Kim, Byounghoon
    Choi, Hyun Chang
    Kwon, Jung Hye
    Choi, Dae Ro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1591 - 1597
12345